Graphics-chip maker Nvidia ( NVDA ) and GE Healthcare, a unit of General Electric ( GE ), have announced a partnership to bring artificial intelligence to GE medical imaging devices in use worldwide to speed the processing of health care data.
[ibd-display-video id=2957934 width=50 float=left autostart=true] The companies announced the partnership Sunday at the annual meeting of the Radiological Society of North America, being held in Chicago through Friday.
Nvidia and GE said they plan to bring sophisticated AI to GE Healthcare's 500,000 imaging devices globally. They announced the new Nvidia-powered Revolution Frontier CT scanner, advancements to the Vivid E95 4D Ultrasound and development of GE Healthcare's Applied Intelligence analytics platform.
The new CT (computed tomography) system in GE's Revolution product family is two times faster in image processing than its predecessor, due to its use of Nvidia's AI computing platform, the companies said in a news release . It is expected to deliver better clinical outcomes in liver lesion detection and kidney lesion characterization because of its speed, Nvidia and GE said.
"Our partnership with GE Healthcare brings together great expertise in medical instruments and AI to create a new generation of intelligent instruments that can dramatically improve patient care," Nvidia Chief Executive Jensen Huang said in a statement.
IBD'S TAKE:Nvidia currently ranks No. 7 on the IBD 50 list of top-performing growth stocks.
GE's Vivid E95 4D Ultrasound System also uses Nvidia graphics processing units to provide fast, accurate visualization and analysis while streamlining workflows, they said.
The new GE Healthcare Applied Intelligence platform will use Nvidia GPUs, the Nvidia Cuda parallel computing platform and Nvidia GPU Cloud container registry to accelerate the creation, deployment and use of deep learning algorithms in health care analytic applications.
"By partnering with Nvidia, GE Healthcare will be able to deliver devices of the future - intelligent machines capable of empowering providers to improve the speed and accuracy of diagnoses for patients around the world," GE Healthcare CEO Kieran Murphy said in a statement.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.